Anti-Trust Cases

WHEN MANUFACTURERS ENGAGE IN ILLEGAL ANTI-TRUST PRACTICES TO KEEP CHEAPER VERSIONS OF THEIR DRUG OFF THE MARKET, AND FORCE UNIONS WE WORK WITH TO PAY EXCESSIVE AMOUNTS FOR PRESCRIPTION DRUGS THEY NEED, WE FIGHT TO END THE PRACTICE – AND TO RETURN ILLEGALLY GAINED PROFITS TO UNION MEMBERS AND THEIR FAMILIES.

We consider it a privilege to be the recognized counsel for numerous organized labor unions on matters pertaining to injuries sustained by their members. In performing this function we come across and even develop new methods of recovering money for union health funds and other union trust funds, which is of keen interest to the fiduciaries of such funds as well as the members they benefit.

Concerned about the High Cost of Prescription Drugs?

Large drug manufacturers will often take measures to prevent generic forms of a retail drug from entering the marketplace. To do so without good cause violates United States Anti-Trust laws. This practice causes union members to pay higher prices for their prescription drugs. If you have not been able to purchase the generic form of Neurontin or Cipro, we can explain why:

Neurontin

We recently assisted in the filing of a class action lawsuit against PFIZER & WARNER-LAMBERT alleging that the companies initiated the filing of sham patent infringement lawsuits to prevent cheaper generic drugs from coming to the marketplace. Such practices directly affect the cost to the consumer. Invariably, we alleged that this practice caused the union health & benefit funds, and others similarly situated, to pay a much higher price for the drug Neurontin. Michael Carney, Business Manager of IUOE Local 94 in New York City, represents the class in the case to protect the monies entrusted to his union and its trustees by his members. The case will benefit members of IUOE Local 94 as well as health & benefit funds across the country.

Cipro

We are currently in the process of litigating a claim against BAYER AG and its U.S. subsidiary, BAYER CORP. We allege that Bayer actually paid generic manufacturers to keep them from producing the generic form of Cipro. We also allege that the generic form should have been available for years, at a much cheaper price to consumers. However, Bayer’s antitrust practices prevented that from occurring.

If you are the trustee of a union and would like to find out how you can determine if your fund was affected by anti-trust practices, contact an attorney at Hach & Rose for an evaluation of your claim.

Health & Benefit Fund Administrators

If you are a Health & Benefit Fund Administrator and are interested in discussing how your union can take part in the process of saving your fund significant costs, contact an attorney at Hach & Rose. We’ll be happy to discuss this exciting process with you.

For Security Purposes we cannot list the names of other potential antitrust cases we are investigating.